AlphaLife Sciences Showcases GenAI-Powered Innovation at Johnson & Johnson Innovation JLABS Global and APAC CEO Summits

CEO Sharon Chen showcased AlphaLife Sciences' AuroraPrime platform at Johnson & Johnson Innovation JLABS Summits, emphasizing GenAI-powered advancements in medical writing and accelerating drug development through streamlined clinical documentation.
Nov 04, 2024 Read More

AlphaLife Sciences Joins NVIDIA Inception Program!

AlphaLife Sciences joins NVIDIA Inception, enhancing the GenAI-powered medical writing solutions to automate and improve clinical research efficiency.
Aug 22, 2024 Read More

Sharing Leading Generative AI-powered Digital Solutions at the DIA Singapore Annual Meeting 2024!

Alice Hsu presented AI-powered clinical trials at DIA 2024, while CEO Sharon Chen shared strategic insights on innovative approaches as a panel expert.
Jul 18, 2024 Read More

AlphaLife Sciences Highlights Generative AI at DIA Global Annual Meeting, Featured on Fox News

At the DIA Global Annual Meeting, AlphaLife showcased advanced generative AI solutions, revolutionizing clinical trials and drug development.
Jun 21, 2024 Read More

AlphaLife Sciences Joins Johnson & Johnson Innovation JLABS Global Roadshow at BIO International Convention

AlphaLife Sciences joined JLABS at the BIO Convention, highlighting support to accelerate medical innovation through AI-driven clinical research.
Jun 10, 2024 Read More

AlphaLife Sciences joins Johnson & Johnson Innovation JLABS

AlphaLife Sciences joins JLABS in Singapore, showcasing its promise to leverage AI for accelerating clinical development and advancing medical AI.
May 25, 2024 Read More

AlphaLife Sciences CEO Joins Microsoft CEO Connection at AI Day Event

AlphaLife Sciences CEO Sharon Chen attended Microsoft Build: AI Day in Bangkok, engaging with CEOs and Satya Nadella on advancing AI and cloud technology.
May 02, 2024 Read More

How AlphaLife uses AI automation to modernize the life sciences industry

AI's ability to analyze vast data can transform scientific research. AlphaPrime develops SaaS products that enhance clinical trials with AI.
Jul 18, 2023 Read More

Connecting with OpenAI, AlphaLife Sciences Opens ChatGPT Function for Digitalization in Clinical Trials

AlphaPrime integrates its AuroraPrime platform with OpenAI, enhancing clinical research with ChatGPT and exploring AGI applications in drug development.
May 09, 2023 Read More

Product Launch: With Intelligent Content Recommendations, Prime Create 2.0 Clinical Research Document Generation System Is Online

On August 17, 2022, AlphaPrime announced updates to AuroraPrime Create 2.0, enhancing clinical document generation with smart features.
Aug 17, 2022 Read More